Illumina Ventures is a corporate venture capital company in California that aims to improve human health by unlocking the power of the genome. Founded 2016 in Foster City, California, United States by Nicholas J. Naclerio, this venture capital firm invests in early stage companies. Its portfolio companies include Stilla Technologies, Ribometrix, Cradle Genomics, Encoded Therapeutics, Inc., DNA Script, LunaDNA, Kallyope, and SQZ Biotech. As of February 2020, Illumina Ventures has made 24 investments. Their most recent investment was on Feb 11, 2020, when Stilla Technologies raised €20M. Illumina Ventures has had two exits, the most notable of which include Human Longevity and Twist Bioscience. The company has raised 2 funds, their latest being Fund I. This fund was announced on Oct 16, 2017 and raised a total of $230M. The company focuses on applications of genomics in life science research, healthcare, agriculture and environmental science, public safety and personal wellness.
Human genome sequencing company founded in 2013 and based in San Diego, CA. Human Longevity Inc. is building a database with genomic and phenotypic information and aims to make medicine more data-driven by combining DNA sequencing, expert analysis and machine learning
Kallyope is a New York City, New York based biotechnology company founded in 2015 developing therapeutics to improve human health by better understanding the gut-brain relationship.
DNA Script is a DNA synthesis company founded by Thomas Ybert, Sylvain Gariel, and Xavier Gordon in 2014, and headquartered in Paris, France.
Luna DNA is company providing a marketplace for genetic data using blockchain based data storage.
Cradle Genomics is a San Diego-based prenatal diagnosis company.
Stilla Technologies' NaicaTM System leverages the key assets of Crystal Digital PCRTM in a compact and reliable digital PCR solution with a single consumable
A diagnostics company using tissue analysis for cancer diagnosis and prognosis
David R. Walt
Senior Accounting Manager
Documentaries, videos and podcasts
Encoded Therapeutics, Inc.